Zimmer Biomet Holdings Inc (NYSE:ZBH)

120.48
Delayed Data
As of Feb 16
 +0.69 / +0.58%
Today’s Change
108.03
Today|||52-Week Range
133.49
-0.16%
Year-to-Date
David Dreman Sells Goldman Sachs, AT&T, CVS
Feb 13 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close119.79
Today’s open119.70
Day’s range118.93 - 121.66
Volume696,599
Average volume (3 months)1,477,666
Market cap$24.4B
Data as of 4:01pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+498.01%
Earnings growth (this year)-2.44%
Earnings growth (next 5 years)+6.20%
Revenue growth (last year)+1.82%
P/E ratio37.7
Price/Sales3.14
Price/Book--

Competitors

----
TFXTeleflex Inc+2.28+0.86%
BSXBoston Scientific Co...+0.11+0.41%
DXCMDexCom Inc+0.63+1.11%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$1.89
Annual revenue (last year)$7.8B
Annual profit (last year)$1.8B
Net profit margin23.51%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Bryan C. Hanson
Senior VP-Global Operations &
Logistics
Adrian Furey
Corporate headquarters
Warsaw, Indiana

Forecasts